Diabetes | Financial Buzz

Healthcare Investing News Market News Technology The Market Buzz

DexCom Published Study on the Cost Effectiveness Of The DexCom G6 Monitoring System

Bryan Shin09/29/2020

709

DexCom, Inc. (NASDAQ: DXCM), an innovator continuous glucose monitoring (CGM) system, reported Tuesday the the publication of its paper, “Long-term Cost-effectiveness of Dexcom G6 Real-time Continuous Glucose Monitoring in Patients with...

Biotechnology Breaking News Buzz On The Street Healthcare Market News Technology The Buzz TV The Market Buzz Top Videos Video

“Buzz on the Street” Show: Nemaura Medical (NASDAQ: NMRD) Appoints Justin Mclarney as CFO

financial buzz09/18/2020

3143

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Nemaura Medical Appoints Justin Mclarney as Chief Finance Officer.” Nemaura Medical, Inc. (NASDAQ: NMRD), a medical...

Biotechnology Breaking News Healthcare Market News Technology The Market Buzz

Breaking News: Nemaura Medical to Present at The LD 500 Virtual Conference

financial buzz08/25/2020

2841

Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT®, its non-invasive and flexible continuous...

Biotechnology Breaking News Buzz On The Street Healthcare Market News Technology The Market Buzz

“Buzz on the Street” Show: Nemaura Medical (NASDAQ: NMRD) Reports First Quarter Financial Results

financial buzz08/18/202009/14/2020

3314

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Nemaura Medical Reports Results and Provides Business Update for the First Quarter Ended June 30, 2020.”...

Biotechnology Breaking News Healthcare Market News Technology The Market Buzz

Breaking News: Nemaura Medical Reports Results and Provides Business Update for the First Quarter Ended June 30, 2020

financial buzz08/17/202008/17/2020

6308

Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company commercializing sugarBEAT®, a non-invasive and flexible continuous glucose monitor (CGM), together with BEAT™diabetes, a health subscription service designed to help...

Tag: Diabetes

DexCom Published Study on the Cost Effectiveness Of The DexCom G6 Monitoring System

“Buzz on the Street” Show: Nemaura Medical (NASDAQ: NMRD) Appoints Justin Mclarney as CFO

Breaking News: Nemaura Medical to Present at The LD 500 Virtual Conference

“Buzz on the Street” Show: Nemaura Medical (NASDAQ: NMRD) Reports First Quarter Financial Results

Breaking News: Nemaura Medical Reports Results and Provides Business Update for the First Quarter Ended June 30, 2020

ABOUT US

Tweets